MRMerck & Co. MRK · NYSE
$145.35 -1.37% (-$2.02)
- Market cap
- $364.0B
- Enterprise value
- $411.0B
- P/E
- 114.7x
- Forward P/E
- 54.6x
- PEG
- 3.0x
- P/S
- 5.5x
- P/FCF
- 22.7x
- EV/EBITDA
- 29.7x
- ROIC
- 5.6%
- Bruto marža
- 75.4%
- Neto marža
- 4.8%
- Dividend yield
- 2.31%
- Payout ratio
- 264.7%
- Neto dolg/EBITDA
- 3.4x
- Beta
- 0.22
- Free float
- 99.9%
O podjetju
Merck & Co., Inc. (MRK) is a global pharmaceutical company with a long history and a broad portfolio of medicinal products. The company focuses on research, development, and manufacturing of drugs and biologics for various diseases, including cardiovascular diseases, oncological conditions, infectious diseases, diabetes, and other serious health conditions. Merck & Co. is known for its innovative pharmaceutical products, which are developed with an emphasis on safety and efficacy. The company has a strong research team that focuses on discovering new drugs and therapeutic approaches. Merck & Co. also collaborates with academic institutions and scientific partners to advance medicines and biotechnologies. The company has a global presence, and its products are distributed worldwide. Merck & Co., Inc. (MRK) shares are an attractive choice for investors who follow the pharmaceutical industry and seek investment opportunities in an established and innovative pharmaceutical company.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert Davis
Employees
74,000
Headquarters
Rahway
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke